Laurence Tiennot-Herment
Président chez Association Française contre les Myopathies
Provenance du réseau au premier degré de Laurence Tiennot-Herment
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Association Française contre les Myopathies
 Association Française contre les Myopathies Miscellaneous Commercial ServicesCommercial Services The Association Française contre les Myopathies is a foundation dedicated to the research, treatment, awareness of neuromuscular diseases, aiming to help improve the patients' expectancy and quality of life. They offer services such as diagnostic tests, home therapy support, and enablement programs for education and daily living. The firm was founded in 1958, and is based in Evry.
21
| Foundation/Endowment | Miscellaneous Commercial Services | 21 |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.
16
| Non-Profit Organization | Biotechnology | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Laurence Tiennot-Herment via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| TRANSGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MOLMED S.P.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EUROFINS CEREP | Miscellaneous Commercial Services | Director/Board Member | |
| Drexel University | College/University | Masters Business Admin | |
Exane SA (Broker)
 Exane SA (Broker) Investment Banks/BrokersFinance Exane SA (Broker) (Exane) is the brokerage division of Exane SA, itself a subsidiary of Verner Investissements SAS in France. Established in 2004 as a joint venture between BNP Paribas and Verner Investissements, the firm is based in Paris and specializes in European equity research and broking activities. Exane has research centers in Paris and London which are supported by a team of economists and strategists. | Investment Banks/Brokers | Analyst-Equity | |
| NEOVACS | Pharmaceuticals: Major | General Counsel | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| ESSEC Business School | College/University | Undergraduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
| University of Strasbourg | College/University | Undergraduate Degree | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| Université Paris II Panthéon Assas | College/University | Doctorate Degree | |
| European Molecular Biology Organization | Corporate Officer/Principal | ||
| University of Ferrara | College/University | Doctorate Degree | |
| BIOPHYTIS S.A. | Pharmaceuticals: Other | Director/Board Member | |
Humanim, Inc.
 Humanim, Inc. Miscellaneous Commercial ServicesCommercial Services Humanim, Inc. provides human services and workforce development resources. Its services include mental health, vocational, neuro-rehabilitation, developmental disabilities and deaf services. The company was founded in 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Founder | |
| Università degli Studi di Modena e Reggio Emilia | College/University | Corporate Officer/Principal | |
Bionest Partners LLC
 Bionest Partners LLC Electronic Equipment/InstrumentsElectronic Technology Bionest Partners, Inc. provides consulting services to the medical industry. The firm offers expertise in all aspects of the life sciences including medical devices, diagnostics, research and development, marketing, corporate development, and personal medicine strategy. The company was founded by Robert J. Easton in 2003 and is headquartered in New York, NY. | Electronic Equipment/Instruments | Founder | |
PPD France SAS
 PPD France SAS Miscellaneous Commercial ServicesCommercial Services PPD France SAS provides technical analyzes,tests and inspection services. The company is headquartered in Ivry sur Seine, France. | Miscellaneous Commercial Services | General Counsel | |
| Università degli Studi di Roma Tor Vergata | College/University | Undergraduate Degree | |
| SENSORION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member General Counsel | |
| Hera Diagnostics SAS | Corporate Officer/Principal | ||
| VALNEVA | Biotechnology | Corporate Officer/Principal | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| San Raffaele-Telethon Institute for Gene Therapy | Director/Board Member | ||
Ouest Angels Developpment SAS
 Ouest Angels Developpment SAS Financial ConglomeratesFinance Ouest Angels Developpment operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Henry De Champsavin in 2007 and is headquartered in Nantes, France. | Financial Conglomerates | Chairman | |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | Director/Board Member | |
| MEDESIS PHARMA S.A. | Biotechnology | Director of Finance/CFO | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Yposkesi
 Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | Biotechnology | Chairman Director/Board Member | |
Coretec Industry Group SAS
 Coretec Industry Group SAS MiscellaneousMiscellaneous Coretec Industry Group SAS operates as a holding French company. The private company is based in Paris, France. | Miscellaneous | Director/Board Member | |
French Tech Hub
 French Tech Hub Information Technology ServicesTechnology Services French Tech Hub provides technical expert services for companies. | Information Technology Services | Corporate Officer/Principal | |
Smart Immune SAS
 Smart Immune SAS BiotechnologyHealth Technology Smart Immune SAS is a clinical-stage biotechnology company based in Paris, France. Smart Immune is developing Protcell, a thymus-empowered T cell progenitor therapy platform to re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The French company aims to improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the EU and the US. Smart101 is already in phase I/II clinical trials in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its Protcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The company is headquartered at Biotech Santé. The company was founded in 2017 by Karine Rossignol, Marina Cavazzana, Isabelle André, with Karine Rossignol as the CEO since 2017. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Orphanse Healthcare SAS | Chairman | ||
| Blueming Advisory SASU | Founder | ||
Atamyo Therapeutics SAS
 Atamyo Therapeutics SAS BiotechnologyHealth Technology Atamyo Therapeutics SAS is a clinical-stage biopharmaceutical company based in France. Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon, a spin-off of gene therapy pioneer Genethon. Atamyo's most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD), with two clinical-stage programs targeting respectively LGMD-R9 and LGMD-R5. The name of the French company is derived from two words\: Celtic Atao which means "always" or "forever" and Myo which is the Greek root for muscle. Atamyo conveys the spirit of its commitment to improve the life of patients affected by neuromuscular diseases with life-long efficient treatments. Atamyo brings to patients with musculoskeletal diseases a new generation of gene therapies with enhanced safety and efficacy. The private company was founded in 2020 by Stéphane Degove and Isabelle Richard. Stéphane Degove has been the CEO since 2020. | Biotechnology | Chairman Director/Board Member | |
Axelia Partners LLC
 Axelia Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Zedra Fund Managers (Guernsey) Ltd., Axelia Partners LLC provides administration, accounting, tax, paralegal and payroll services. The company is based in Cambridge, MA. The company was founded in 1989 by Marie-Yvonne Landel-Meunier. Axelia Partners was acquired by Zedra Fund Managers (Guernsey) Ltd. on November 14, 2022. | Miscellaneous Commercial Services | Founder | |
| Women Initiative Foundation | Corporate Officer/Principal | ||
| Institut Colisée | Founder | ||
| Les Mauvais Elèves | Founder |
Statistiques
Internationale
| France | 32 |
| Etats-Unis | 12 |
| Italie | 6 |
| Royaume-Uni | 3 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Finance | 3 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 49 |
| Corporate Officer/Principal | 23 |
| Chief Tech/Sci/R&D Officer | 10 |
| Chairman | 6 |
| Independent Dir/Board Member | 6 |
Relations les plus connectées
- Bourse
- Insiders
- Laurence Tiennot-Herment
- Connexions Sociétés
